Friday, Dec 02, 2022
×
Outlook.com
×

Lupin Generic Drug

Lupin Gets USFDA Nod To Market Generic Drug

The company has received tentative approval from the United States Food and Drug Administration for its abbreviated new drug application for Tenofovir Alafenamide tablets

18 April 2022

File Photo.

Lupin Acquires Portfolio Of Brands From Anglo-French Drugs & Industries

The acquisition will strengthen the company's India formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements, and neurological products.


Lupin Receives USFDA Approval For Anti-Depressant Drug

The approval granted by the US Food and Drug Administration is for the abbreviated new drug application Desvenlafaxine extended-release tablets of strength 25 mg, the company said in a regulatory filing.

14 April 2022

Lupin Gets USFDA Nod For Generic Product

The Mumbai-based company's product is the generic version of Viatris Specialty LLC's Revatio


Lupin Launches Generic Contraceptive Drug In US

The Mumbai-based drug maker has launched the product in the US market under exclusive license, marketing and distribution agreement with Slayback Pharma LLC

07 April 2022

Advertisement

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement